Monoclonal antibodies against macrophage colony-stimulating factor diminish the number of circulating intermediate and nonclassical (CD14++CD16+/CD14+CD16++) monocytes in rheumatoid arthritis patient
Abstract
| Authors: | Korkosz M, Bukowska-Strakova K, Sadis S, Grodzicki T, Siedlar M |
|---|---|
| Journal: | Blood. ;119(22):5329-30 |
| Year: | 2012 |
| PubMed: | Find in PubMed |